Alume Biosciences

La Jolla, CA · Founded 2017 · Privately Held (backing)

Developer of a nerve illumination technology designed to help doctors perform precision surgery. Alume Biosciences is based in La Jolla, CA and was founded in 2017. Its last reported valuation was $128 million in Jan 2023. It has raised $31.2 million across 6 recorded rounds; the latest was a $2.2 million seed round in Mar 2026.

Last reported valuation
$127.8M
Oct 2026
Priced at
—
Total raised
$31.2M
Last round
Seed Round
Mar 2026

Alume Biosciences key facts

as of Oct 2026
  • Developer of a nerve illumination technology designed to help doctors perform precision surgery.
  • Alume Biosciences is valued at approximately $127.8M as of Oct 2026 (last reported valuation).
  • It has raised $31.2M across 6 recorded rounds; the latest was Seed Round ($2.2M) in Mar 2026.
  • Notable investors include University of California, Johnson & Johnson Innovation - JLABS, ALMA Life Sciences, Biobrit, Chrysa Mineo — 10 tracked in total.
  • Alume Biosciences has filed 7 Form Ds with the SEC since 2019, most recently May 2026 ($2.2M sold to 4 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$127.8M

Alume Biosciences's last reported valuation, Jan 2023. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Alume Biosciences with a free account
  • ·Watch Alume Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Alume Biosciences funding rounds

6 rounds
Mar 2026Seed Round$2.2MSEC filing▮
Oct 2025Early Stage VC$6.9MSEC filing▮
Dec 2022Early Stage VC$12.8MSEC filing▮
Apr 2022Seed Round$4.0MSEC filing▮
Aug 2020Seed Round$4.0MSEC filing▮

Alume Biosciences valuation

Alume Biosciences's last reported valuation was $128 million in Jan 2023. No priced round, secondary trade or fund mark has surfaced since.

How much has Alume Biosciences raised?

Alume Biosciences has raised $31.2 million across 6 recorded rounds since 2019. The largest was a $6.9 million early-stage round in Oct 2025; the most recent was a $2.2 million seed round in Mar 2026.

Alume Biosciences has filed 7 Form Ds with the SEC since 2019, most recently in May 2026 ($2.2 million sold to 4 investors).

Alume Biosciences investors

10 investors are on record for Alume Biosciences, including University of California, Johnson & Johnson Innovation - JLABS, ALMA Life Sciences and Biobrit. The seed round in Mar 2026 drew 4 investors.

About Alume Biosciences

Developer of a nerve illumination technology designed to help doctors perform precision surgery. The company's technology illuminates nerves during surgery, making them visible to the surgical team, enabling surgeons to prevent nerve damage while performing complex organ surgeries.

Sector
Healthcare
HQ
La Jolla, CA, United States
Founded
2017
Employees
11
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.